IDYA · NASDAQ · Biotechnology

IDEAYA Biosciences (IDYA)

Develops biomarker-selected cancer drugs across small molecules and antibody-drug conjugates.

$39.71
After hours+0.01 (+0.04%)
At close$39.70(+2.15%)